New York State Common Retirement Fund’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-71
| Closed | -$1K | – | 3449 |
|
|
2022
Q2 | $1K | Sell |
71
-4,742
| -99% | -$45.3K | ﹤0.01% | 3414 |
|
|
2022
Q1 | $91K | Hold |
4,813
| – | – | ﹤0.01% | 3042 |
|
|
2021
Q4 | $86K | Sell |
4,813
-6
| -0.1% | -$180 | ﹤0.01% | 3116 |
|
|
2021
Q3 | $179K | Buy |
4,819
+17
| +0.4% | +$754 | ﹤0.01% | 2947 |
|
|
2021
Q2 | $286K | Buy |
4,802
+60
| +1% | +$3.63K | ﹤0.01% | 2876 |
|
|
2021
Q1 | $318K | Buy |
4,742
+1,240
| +35% | +$97.1K | ﹤0.01% | 2666 |
|
|
2020
Q4 | $212K | Hold |
3,502
| – | – | ﹤0.01% | 2741 |
|
|
2020
Q3 | $277K | Hold |
3,502
| – | – | ﹤0.01% | 2508 |
|
|
2020
Q2 | $219K | Hold |
3,502
| – | – | ﹤0.01% | 2597 |
|
|
2020
Q1 | $186K | Sell |
3,502
-480
| -12% | -$47.6K | ﹤0.01% | 2497 |
|
|
2019
Q4 | $482K | Buy |
3,982
+400
| +11% | +$57.5K | ﹤0.01% | 2316 |
|
|
2019
Q3 | $650K | Hold |
3,582
| – | – | ﹤0.01% | 2201 |
|
|
2019
Q2 | $466K | Sell |
3,582
-1,099
| -23% | -$197K | ﹤0.01% | 2409 |
|
|
2019
Q1 | $1.14M | Buy |
4,681
+1,099
| +31% | +$291K | ﹤0.01% | 1889 |
|
|
2018
Q4 | $682K | Buy |
3,582
+140
| +4% | +$34.1K | ﹤0.01% | 2124 |
|
|
2018
Q3 | $1.13M | Hold |
3,442
| – | – | ﹤0.01% | 2023 |
|
|
2018
Q2 | $1.07M | Sell |
3,442
-1,665
| -33% | -$509K | ﹤0.01% | 2059 |
|
|
2018
Q1 | $1.24M | Buy |
5,107
+348
| +7% | +$97.6K | ﹤0.01% | 1890 |
|
|
2017
Q4 | $1.44M | Hold |
4,759
| – | – | ﹤0.01% | 1826 |
|
|
2017
Q3 | $1.26M | Hold |
4,759
| – | – | ﹤0.01% | 1892 |
|
|
2017
Q2 | $1.25M | Sell |
4,759
-4,969
| -51% | -$1.24M | ﹤0.01% | 1923 |
|
|
2017
Q1 | $3.5M | Hold |
9,728
| – | – | ﹤0.01% | 1400 |
|
|
2016
Q4 | $2.81M | Buy |
9,728
+723
| +8% | +$224K | ﹤0.01% | 1505 |
|
|
2016
Q3 | $3.07M | Sell |
9,005
-394
| -4% | -$144K | ﹤0.01% | 1446 |
|
|
2016
Q2 | $4M | Buy |
9,399
+522
| +6% | +$215K | 0.01% | 1323 |
|
|
2016
Q1 | $2.84M | Buy |
8,877
+611
| +7% | +$208K | ﹤0.01% | 1445 |
|
|
2015
Q4 | $4.29M | Sell |
8,266
-353
| -4% | -$130K | 0.01% | 1294 |
|
|
2015
Q3 | $2.52M | Buy |
8,619
+1,471
| +21% | +$523K | ﹤0.01% | 1497 |
|
|
2015
Q2 | $2.81M | Sell |
7,148
-2,311
| -24% | -$815K | ﹤0.01% | 1685 |
|
|
2015
Q1 | $2.86M | Buy |
9,459
+1,647
| +21% | +$402K | ﹤0.01% | 1494 |
|
|
2014
Q4 | $1.74M | Buy |
7,812
+1,186
| +18% | +$245K | ﹤0.01% | 1668 |
|
|
2014
Q3 | $1.54M | Hold |
6,626
| – | – | ﹤0.01% | 1724 |
|
|
2014
Q2 | $1.46M | Buy |
+6,626
| New | +$1.47M | ﹤0.01% | 1774 |
|
Other funds holding TXMD
RCMNY
JGC
SMH
SFI
GF
New York State Common Retirement Fund's TXMD Position: Q3 2022 in Review
New York State Common Retirement Fund sold out of TherapeuticsMD (TXMD) in Q3 2022, closing a stake of 71 shares — an estimated $1K sold.
New York State Common Retirement Fund first reported a position in TXMD in Q2 2014 and held it in 33 quarters. The position peaked at $4.29M in Q4 2015. 43 funds tracked by Wall St. Rank hold TXMD as of Q3 2022.
- New York State Common Retirement Fund reported no remaining TherapeuticsMD position as of Q3 2022 after selling out during the quarter.
- New York State Common Retirement Fund sold 71 TherapeuticsMD shares in Q3 2022, an estimated $1K.
- New York State Common Retirement Fund first reported a position in TherapeuticsMD in Q2 2014 and held it in 33 quarters.
- New York State Common Retirement Fund's TherapeuticsMD position peaked at $4.29M in Q4 2015.
- 43 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2022.
Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.